Japan’s Health Ministry has warned that Eli Lilly’s breast cancer therapy Verzenio could have serious side effects for patient’s lungs.
The health ministry said Verzenio is suspected of adversely affecting patients’ lungs after 14 patients developed a serious lung disease and three died.
The drug has been blamed for at least four of the 14 cases of lung disease, one of which resulted in death.